文献库搜索 | GeneLibs

Thibault(C),Blons(H),Allory(Y),Harba(A),Ro... Eur Urol Oncol 2026-07-08

...PIK3CA mutations, loss of chromosome 9, and widespread chromatin-remodeling gene alterations. MIBC displays high genomic...

Zhang(M),Niu(L),Lyu(H),Liu(Z),Zeng(H),Lu(Z... Chin Med J (Engl) 2026-07-07

...PIK3CA and BRCA1/2. Based on dose-limiting toxicities and preliminary efficacy, daily famitinib 10 mg combined with dalp...

Navaei(M),Karami(F),Jahanimoghadam(A),Zare... Cancer Invest 2026-07-09

...PIK3CA, BRAF, EGFR, ERBB2, FGFR3, MTOR, and TP53, along with KRAS, MET, and FGFR2, emerged as potential biomarkers. Addi...

Alvarez-Palacios(O),Ojeda-Campos(L),Rodríg... Rare Tumors None

...PIK3CA). The disease progressed rapidly despite CHOP chemotherapy, and the patient died shortly after diagnosis. This re...

Chou(LP),Lee(MY),Fang(CL),Tung(CL),Lin(IL)... Front Med (Lausanne) None

...PIK3CA, and PTEN mutations. Initially, he received trastuzumab and pembrolizumab. However, there was no clinical respons...

Hao(Z),Meng(T),Li(S),Bu(Y),Qie(R),Chen(J) Rejuvenation Res 2026-07-09

...PIK3CA, PIK3CD, and mTOR; docking supported feasible engagement. In vivo, YZDHD improved spatial learning and recognitio...

Zhang(X),Guan(M),Wang(Y),Ding(C),Yu(X),Shi... Cell Signal 2026-11-00

...PIK3CA and HIF1A. Furthermore, through analysis of the HERB and CTD databases and molecular docking simulations, we unco...

Mabvakure(BM),Promprasert(P),Martinez Cruz... medRxiv 2026-06-29

...PIK3CA, and TP53 , as well as in pathogenic variant occurrence. Geographic origin and age of onset appear to shape the C...

Altamimi(O),Altamimi(I),Alhowidi(R),Alosai... Cureus 2026-06-00

...PIK3CA-related overgrowth spectrum and selected vascular malformations, has shifted the management paradigm. These agent...

El-Sayed(ASA),Refaat(S),El-Sayed(MA),Fikry... Appl Microbiol Biotechnol 2026-07-10

...PIK3CA, mTOR, and HSP90, in addition to binding the β-tubulin taxane site, highlighting its capacity to modulate multipl...